This means you can access doctor consultations, your medication, and lab work all from the comfort of your home
[35] reported that a 6-month exenatide-based therapy produced a 42% relative reduction in intrahepatic lipid content, accompanied by a mean BW loss of 5 kg and significant decreases in both abdominal subcutaneous and visceral fat volumes
People with a history of severe gastrointestinal issues, such as gastroparesis (delayed stomach emptying), should avoid this medication, as it can exacerbate these conditions
Mazdutide has demonstrated excellent weight loss and glucose-lowering effects in clinical studies, as well as reducing waist circumference, blood lipids, blood pressure, serum uric acid, liver enzymes, liver fat content and improved insulin sensitivity